TSC2 and tuberous sclerosis: Given that a high mutation rate of GAP (GTPase activating protein) domain of TSC2 was observed in TSC patients and TSC2 shares a homologous GAP domain with Rap1-GAP, Zhang et al. reasoned that a GTPase would be a direct target for TSC2 in regulating mTORC1 activation [64].